HDAC2 Is Involved in the Regulation of BRN3A in Melanocytes and Melanoma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HDAC2 Is Involved in the Regulation of BRN3A in Melanocytes and Melanoma
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 2, Pages 849
Publisher
MDPI AG
Online
2022-01-13
DOI
10.3390/ijms23020849
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The ORC ubiquitin ligase OBI1 promotes DNA replication origin firing
- (2019) Philippe Coulombe et al. Nature Communications
- C-Jun drives melanoma progression in PTEN wild type melanoma cells
- (2019) Melanie Kappelmann-Fenzl et al. Cell Death & Disease
- The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion
- (2018) Saskia Anna Graf et al. Pigment Cell & Melanoma Research
- DSS1 promoter hypomethylation and overexpression predict poor prognosis in melanoma and squamous cell carcinoma patients
- (2017) Mario Venza et al. HUMAN PATHOLOGY
- Histone Deacetylase Inhibitors as Anticancer Drugs
- (2017) Tomas Eckschlager et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Melanoma subtypes demonstrate distinct PD-L1 expression profiles
- (2017) Genevieve J Kaunitz et al. LABORATORY INVESTIGATION
- GeneHancer: genome-wide integration of enhancers and target genes in GeneCards
- (2017) Simon Fishilevich et al. Database-The Journal of Biological Databases and Curation
- Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinoma
- (2017) Cathrin Ritter et al. Scientific Reports
- Inhibition of histone deacetylases in melanoma-a perspective from bench to bedside
- (2016) Eva Hornig et al. EXPERIMENTAL DERMATOLOGY
- A Bifunctional Approach of Immunostimulation and uPAR Inhibition Shows Potent Antitumor Activity in Melanoma
- (2016) Fanny Matheis et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The molecular hallmarks of epigenetic control
- (2016) C. David Allis et al. NATURE REVIEWS GENETICS
- Lateral Thinking: How Histone Modifications Regulate Gene Expression
- (2016) Moyra Lawrence et al. TRENDS IN GENETICS
- Reversal of epigenetic silencing of MHC class I chain-related protein A and B improves immune recognition of Merkel cell carcinoma
- (2016) Cathrin Ritter et al. Scientific Reports
- HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade
- (2015) D. M. Woods et al. Cancer Immunology Research
- Expression of Class I Histone Deacetylases Indicates Poor Prognosis in Endometrioid Subtypes of Ovarian and Endometrial Carcinomas
- (2015) Wilko Weichert et al. NEOPLASIA
- The neural crest transcription factor Brn3a is expressed in melanoma and required for cell cycle progression and survival
- (2013) Tobias Hohenauer et al. EMBO Molecular Medicine
- POU transcription factors in melanocytes and melanoma
- (2013) Robert Besch et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Selective Inhibition of p300 HAT Blocks Cell Cycle Progression, Induces Cellular Senescence, and Inhibits the DNA Damage Response in Melanoma Cells
- (2013) Gai Yan et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The antimelanoma activity of the histone deacetylase inhibitor panobinostat (LBH589) is mediated by direct tumor cytotoxicity and increased tumor immunogenicity
- (2013) David M. Woods et al. MELANOMA RESEARCH
- Skin melanocytes: biology and development
- (2013) Mirosława Cichorek et al. Postepy Dermatologii i Alergologii
- Multiple roles of class I HDACs in proliferation, differentiation, and development
- (2012) Nina Reichert et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Epigenetic regulation by decitabine of melanoma differentiation in vitro and in vivo
- (2011) Oscar Alcazar et al. INTERNATIONAL JOURNAL OF CANCER
- Virtual Ligand Screening of the p300/CBP Histone Acetyltransferase: Identification of a Selective Small Molecule Inhibitor
- (2010) Erin M. Bowers et al. CHEMISTRY & BIOLOGY
- Vorinostat Plus Bortezomib for the Treatment of Relapsed/Refractory Multiple Myeloma: A Case Series Illustrating Utility in Clinical Practice
- (2010) Amitabha Mazumder et al. Clinical Lymphoma Myeloma & Leukemia
- Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell Identities
- (2010) Sven Heinz et al. MOLECULAR CELL
- Histone H3K27ac separates active from poised enhancers and predicts developmental state
- (2010) M. P. Creyghton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neuronal transcription factor Brn-3a(l) is over expressed in high-grade ovarian carcinomas and tumor cells from ascites of patients with advanced-stage ovarian cancer
- (2010) Nuzhat Ahmed et al. Journal of Ovarian Research
- The 14-3-3σ gene promoter is methylated in both human melanocytes and melanoma
- (2009) Suhu Liu et al. BMC CANCER
- Phase I Study of Vorinostat in Combination with Bortezomib for Relapsed and Refractory Multiple Myeloma
- (2009) A. Badros et al. CLINICAL CANCER RESEARCH
- Melanocytes in development and cancer
- (2009) Audrey Uong et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon–independent apoptosis in human melanoma cells
- (2009) Robert Besch et al. JOURNAL OF CLINICAL INVESTIGATION
- Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy
- (2008) W Weichert et al. BRITISH JOURNAL OF CANCER
- HDAC expression and clinical prognosis in human malignancies
- (2008) Wilko Weichert CANCER LETTERS
- Class I Histone Deacetylase Expression Has Independent Prognostic Impact in Human Colorectal Cancer: Specific Role of Class I Histone Deacetylases In vitro and In vivo
- (2008) W. Weichert et al. CLINICAL CANCER RESEARCH
- Prognostic significance of the therapeutic targets histone deacetylase 1, 2, 6 and acetylated histone H4 in cutaneous T-cell lymphoma
- (2008) L Marquard et al. HISTOPATHOLOGY
- Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis
- (2008) Wilko Weichert et al. LANCET ONCOLOGY
- A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas
- (2008) S Balasubramanian et al. LEUKEMIA
- MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo
- (2008) M. Fournel et al. MOLECULAR CANCER THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More